Saturday 17 October 2026 Export GSK’s income statement to Excel — free account

GSK PLC Sponsored ADR

GSK Healthcare Drug Manufacturers General

GSK PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $43.1 billion, up 7.44% from fiscal 2024. In the quarter to June 2026, revenue grew 5.81%, EPS fell 69.5%, free cash flow grew 54.8% and total debt rose 5.61%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

49.55 0.53 +1.08%

Follow GSK

Alert me

Market cap: $98.2B
P/E: 15.4×
Fwd P/E: 12.4×
Dividend yield: 3.67%
F-score: 9/9
Altman Z: 2.12
Beneish M: −2.46
Dividend safety: 54/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	12.16	13.22	14.26	16.33
P/S ratio Full definition →		2.07	2.31	2.53	2.36
P/FCF ratio Full definition →		13.52	15.39	16.97	13.76
P/Operating CF Full definition →		28.68	34.92	72.20	29.19
P/B ratio Full definition →		4.10	4.72	4.73	4.56
Price to Tangible BV Full definition →		0.00	0.00	0.00	0.00
EV/Sales Full definition →		2.53	2.74	3.01	2.82
EV/EBITDA Full definition →		7.57	8.74	9.85	9.80
EV/Operating CF Full definition →		10.38	11.56	12.81	11.38
EV/FCF Full definition →		16.52	18.29	20.17	16.40
Quick Ratio Full definition →		0.55	0.53	0.51	0.52
Current Ratio Full definition →		0.84	0.82	0.79	0.82
Net Debt/EBITDA Full definition →		4.28	21.84	5.63	5.43
Debt/Assets Full definition →		28.94%	28.99%	30.31%	29.54%
Debt/Equity Full definition →		1.13	1.11	1.09	1.06
Asset Turnover Full definition →		0.53	0.55	0.54	0.55
Operating CF/Net income Full definition →		1.12	3.34	0.66	6.17
Capex/Depreciation Full definition →		(1.12)	2.08	(0.76)	(0.16)
Interest Coverage Full definition →		15.53	5.90	13.73	2.64
Research and Development Expense of Revenue Full definition →		19.76%	27.15%	22.18%	41.22%
Selling, General and Administrative Expense of Revenue Full definition →		26.20%	30.64%	27.78%	26.19%
Intangible Assets out of Total Assets Full definition →		0.39	0.39	0.40	0.39
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Graham Net Nets Full definition →		(0.43)	(0.37)	(0.34)	(0.34)
Graham Number Full definition →		29.00	29.45	31.88	28.80
Earnings Yield Full definition →		8.23%	7.57%	7.01%	6.12%
Free Cash Flow Yield Full definition →		7.40%	6.50%	5.89%	7.27%
Revenue per Share Full definition →		5.71	5.64	5.11	5.62
Operating CF per Share Full definition →		1.50	1.40	0.76	1.80
Capex per Share Full definition →		(0.57)	(0.63)	(0.24)	(0.24)
Free Cash Flow per Share Full definition →		0.94	0.77	0.53	1.56
Cash per Share Full definition →		2.28	2.30	2.36	2.14
Shareholders Equity per Share Full definition →		10.53	10.39	11.67	11.49
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		10.53	10.39	11.67	11.49
Free Cash Flow Full definition →		1,893.07	1,567.56	1,060.48	3,126.87
Working Capital Full definition →		(4,706.87)	(5,117.87)	(6,290.13)	(5,334.85)
Capital Expenditures Full definition →		(1,141.83)	(1,276.93)	(477.01)	(477.22)
Net Current Asset Value Full definition →		(37,397.49)	(36,464.69)	(37,306.88)	(36,239.39)
EV/EBIT Full definition →		10.73	11.29	12.26	14.41
Capex to Sales Full definition →		0.10	0.11	0.05	0.04
Price to Operating Income Full definition →		8.78	9.50	10.32	12.09
Other line items
Average Receivables Full definition →		10,712.39	9,796.20	10,071.31	10,558.12
Average Payables Full definition →		19,912.23	19,939.76	19,198.29	19,521.00
Average Inventory Full definition →		7,971.70	7,528.20	7,926.78	8,270.42
Average Assets Full definition →		79,088.69	78,292.04	80,586.97	81,001.78
Average Common Equity Full definition →		19,364.55	18,881.89	20,336.68	21,112.23

Show all line items

Columns are period end dates

Stockrow Weekly